Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial
Veerle Stouten, René Westhovens, Sofia Pazmiño, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Topics & Concepts
MedicineRheumatoid arthritisInternal medicineMethotrexateAdverse effectObservational studyPhysical therapySurgeryRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchSpondyloarthritis Studies and Treatments